• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Preterm Birth Drug Withdrawn After 12 Years

The New York Times – Business:

The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.

Christina Jewett
Author: Christina Jewett

This post first appeared in The New York Times – Business. Read the original article.

Written by

Christina Jewett

in

Covis Pharma Group, Drugs (Pharmaceuticals), Food and Drug Administration, Pregnancy and Childbirth, Premature Babies, Recalls and Bans of Products
←Keanu Reeves Reveals He Still Owns This Epic Souvenir From The ‘Matrix’ Set
Kevin McCarthy Defends Giving Fox News’ Tucker Carlson Jan. 6 Footage→

More posts

  • Salesforce reportedly planning $25 billion bond sale to help fund $50 billion buyback

  • Yann LeCun raises $1 billion for his Advanced Machine Intelligence Labs, breaking European records

  • Officer shot in ‘active shooter incident’ in Baltimore, suspect also shot: Police

  • Op-Ed: Rev. Jesse Jackson’s HBCU Roots Show How Student Leadership Shapes Black Political Power

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube